We’re On a Mission

AlloVir is advancing a pipeline of allogeneic, off-the-shelf, virus-specific T cell therapies to prevent or treat life-threatening viral diseases

Partner with Us

We welcome discussions with industry, government and non-profit organizations about potential partnership and licensing opportunities that can facilitate and expedite the delivery of our therapies to patients in need, including:

  • Global and regional licensing opportunities across our pipeline, including our investigational SARS-CoV-2 specific VST therapy, ALVR109
  • Co-development or co-commercialization partnerships
  • Research and development collaborations to explore new indications, new patient populations, or new applications for our VST platform


To discuss partnering with AlloVir, please submit an inquiry to:
bd@allovir.com

Ongoing Partnerships

Baylor College of Medicine
Our technology platform was developed by world-class scientists at the Baylor College of Medicine’s Center for Cell and Gene Therapy. We continue to collaborate on basic and translational research of novel cell therapies through sponsored research agreements.

AlloVir is the global leader in developing VST immunotherapies

We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases.

Our Pipeline

Our allogeneic, off-the-shelf VST therapy candidates target 12 different devastating viruses as treatment or prevention.
view

Our Platform

Our proprietary platform develops allogeneic, off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies.
learn

Our People

We are united in purpose around a singular mission to prevent and defeat life-threatening viral diseases.
meet
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?